Analyst consensus rating
Standard BioTools Analyst Rating: none
Direct answer
Standard BioTools's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $1.35.
Forecast evidence checked October 17, 2026.
Get free Standard BioTools email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.63
- Average price target
- $1.35
- High price target
- $1.35
- Low price target
- $1.35
- Low target gap
- +114.6%
- Target upside
- +114.6%
- High target gap
- +114.6%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Standard BioTools?
Standard BioTools has a verified none consensus. The same dataset has an average price target of $1.35.
How far are Standard BioTools's low and high targets from the recorded price?
The low target implies +114.6%, while the high target implies +114.6%.
How many analysts are included in Standard BioTools's consensus?
The verified consensus includes 1 analysts.
How is Standard BioTools's target upside or downside calculated?
The average target of $1.35 is divided by the recorded price of $0.63, then one is subtracted to produce +114.6%. This does not guarantee a future return.
When was Standard BioTools's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.